🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New drug pricing report: 💊 40 brand drug list prices went up in February, 3 saw drops 📈 Increlex shot up 150% 📉 Acetadote dropped 88.7% 📊 Year-over-year generic oral solid deflation came in at 13.4% Receipts: 46brooklyn.com/news/a-frigid-…

“By every other metric, one would assume that pharmacy need and access would be on the uptick. The opposite actually occurred.” - Antonio Ciaccia Marty Schladen ohiocapitaljournal.com/2025/03/19/ohi…

“The reality is that government demands for discounts actually run counter-intuitive to the goal of low drug prices.” - Antonio Ciaccia pharmalot statnews.com/pharmalot/2025…

New drug pricing report: 💊 11 brand list prices went up in March; 2 went down 📈 Keytruda increased 2% and Ultiva increased 9.9% 📉 Gamifant decreased 10.2% 📊 YoY deflation on oral solid generics came in at 12.1% Receipts: 46brooklyn.com/news/drug-pric…

healio.com/news/rheumatol…

“I don't see a lot of ‘the how’ … And ‘the how’ is always the rub when it comes to fixing drug pricing problems in the U.S." - Antonio Ciaccia Ken Alltucker usatoday.com/story/news/pol…

Worlds collide! For the first time ever, Adam J. Fein and Antonio Ciaccia will link up for special webinar digging into the state of retail pharmacy. Registration now open! drugchannelsinstitute.com/products/webin…

Cassidy urges congressional reforms to 340B drug discount program after investigation Zach Brennan endpts.com/cassidy-urges-…

We’re two weeks away from our retail pharmacy rendezvous with Adam J. Fein. Sign up now: 46brooklyn.com/news/2025/6/4/…

Team up time! Join Antonio Ciaccia and me on June 20 for an epic live-stream event that will dig into the wild state of the retail pharmacy marketplace 46brooklyn.com/news/2025/6/4/… drugch.nl/june2025 Antonio Ciaccia 46brooklyn Research

𝐖𝐡𝐚𝐭’𝐬 𝐍𝐞𝐱𝐭 𝐟𝐨𝐫 𝐑𝐞𝐭𝐚𝐢𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐲: 𝐃𝐚𝐭𝐚, 𝐃𝐞𝐛𝐚𝐭𝐞, 𝐚𝐧𝐝 𝐃𝐢𝐬𝐫𝐮𝐩𝐭𝐢𝐨𝐧 🗓️ Friday, June 20, 2025 🕛 12:00–1:30 p.m. ET | Live on Zoom 👉 Register here: drugch.nl/june2025 Join Adam J. Fein and Antonio Ciaccia 46brooklyn Research for a new

The 3 types of PBM reform aiming to change the pharmaceutical market Drug Topics drugtopics.com/view/the-3-typ…

How PBMs gained notoriety in the prescription drug market Drug Topics drugtopics.com/view/how-pbms-…

🚨𝑻𝑯𝑰𝑺 𝑭𝑹𝑰𝑫𝑨𝒀🚨 𝐖𝐡𝐚𝐭’𝐬 𝐍𝐞𝐱𝐭 𝐟𝐨𝐫 𝐑𝐞𝐭𝐚𝐢𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐲: 𝐃𝐚𝐭𝐚, 𝐃𝐞𝐛𝐚𝐭𝐞, 𝐚𝐧𝐝 𝐃𝐢𝐬𝐫𝐮𝐩𝐭𝐢𝐨𝐧 🗓️ Friday, June 20, 2025 🕛 12:00–1:30 p.m. ET | Live on Zoom 👉 Register here: drugch.nl/june2025 Join Adam Fein Drug Channels

“Pharmacies want to get paid more, PBMs want to pay less, and directionally, that is a good thing.” - Antonio Ciaccia drugtopics.com/view/misconcep…

Today’s the day. Last chance to sign up!

If you’ve ever wondered why drug pricing is an opaque complicated mess, just remember that it is explicitly designed that way. Our CEO Antonio Ciaccia tears open the black box and reveals its dysfunction for Ohio’s Joint Medicaid Oversight Committee: ohiochannel.org/video/ohio-joi…

States across the country have enacted laws that restrain a PBM’s ability to force or steer patients to use their affiliated pharmacies. Here’s how vertical integration and new PBM subsidiaries can thwart those laws. Welcome to Private Label Park. 46brooklyn.com/research/welco…

Recently, #PBMs have started to adopt their own “house brand” logic to pharmaceuticals by creating offshore subsidiaries that buy FDA-approved products in bulk, wrap them in exclusive labels, and then prefer those products on their own formularies. | 46brooklyn Research

Must read piece by 46brooklyn Research where they expose another practice in PBMs ever evolving bag of tricks by preferring not only their affiliated pharmacies but also their own drug labels. Steering ontop of steering. Amazing.